These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1334538)
1. A further application of 99Tcm-MAG3 in children. Chapman S; Mountford PJ; Boivin CM; Burrell DN Nucl Med Commun; 1992 Dec; 13(12):897-8. PubMed ID: 1334538 [No Abstract] [Full Text] [Related]
2. Replacing 99Tcm-DMSA for renal imaging? Piepsz A; Pintelon H; Verboven M; Keuppens F; Jacobs A Nucl Med Commun; 1992 Jul; 13(7):494-6. PubMed ID: 1323086 [TBL] [Abstract][Full Text] [Related]
3. Can technetium-99m-mercaptoacetyltriglycine replace technetium-99m-dimercaptosuccinic acid in the exclusion of a focal renal defect? Gordon I; Anderson PJ; Lythgoe MF; Orton M J Nucl Med; 1992 Dec; 33(12):2090-3. PubMed ID: 1334134 [TBL] [Abstract][Full Text] [Related]
4. 99Tcm-mercapto acetyl triglycine in paediatric renal tract disease. Pickworth FE; Vivian GC; Franklin K; Brown EF Br J Radiol; 1992 Jan; 65(769):21-9. PubMed ID: 1336693 [TBL] [Abstract][Full Text] [Related]
5. 99mTc-MAG3 and 99mTc-DMSA in the detection and assessment of pyelonephritis. Tamgac F; Moretti JL; Rocchisani JM; Baillet G; Weinmann P J Nucl Biol Med (1991); 1993 Jun; 37(2):62-4. PubMed ID: 8396978 [TBL] [Abstract][Full Text] [Related]
6. Is there still a need for Tc-99m DMSA renal imaging? Bair HJ; Becker W; Schott G; Kühn RH; Wolf F Clin Nucl Med; 1995 Jan; 20(1):18-21. PubMed ID: 7895429 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of residual renal function and prediction of the prognosis of polycystic kidney disease by 99m Tc-dimercaptosuccinic acid (DMSA) renal scintigraphy. Kawamura J; Yoshida O Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):1031-4. PubMed ID: 6275152 [No Abstract] [Full Text] [Related]
8. 99Tcm-MAG3 for quantitation of differential renal function. Llamas-Elvira JM; Martinez-Paredes M; Jimenez-Heffernan A; Sopena R; Requena MJ; Gonzalez FM; Torres M; Mateo A Nucl Med Commun; 1989 Oct; 10(10):759-64. PubMed ID: 2559380 [TBL] [Abstract][Full Text] [Related]
9. Vicarious excretion of technetium-99m MAG3 in a patient with polycystic renal disease. Wulfeck DW; Sakow NK; Senler SO Clin Nucl Med; 1993 Mar; 18(3):239-40. PubMed ID: 8462218 [No Abstract] [Full Text] [Related]
10. Tc-99m MAG3 demonstration of polycystic kidneys in tuberous sclerosis. Mansberg VJ; Rossleigh MA; Murray IP Clin Nucl Med; 1997 Aug; 22(8):555-6. PubMed ID: 9262904 [No Abstract] [Full Text] [Related]
11. [Renal scintigraphy in the study of renal malformations]. Silvestro L Minerva Pediatr; 1983 Nov; 35(22):1097-103. PubMed ID: 6323942 [No Abstract] [Full Text] [Related]
12. Radionuclide renal imaging in the United States. Gates GF Eur J Nucl Med; 1995 Sep; 22(9):1081-4. PubMed ID: 7588949 [No Abstract] [Full Text] [Related]
13. Inter-observer agreement in the reporting of 99Tcm-DMSA renal studies. Piepsz A; Ham HR Nucl Med Commun; 1996 Dec; 17(12):1072. PubMed ID: 9004306 [No Abstract] [Full Text] [Related]
14. Measurement of the extravascular concentration of renal agents following intravenous bolus injection. Peters AM; Brown H; Cosgriff P Nucl Med Commun; 1994 Feb; 15(2):66-72. PubMed ID: 8170640 [TBL] [Abstract][Full Text] [Related]
15. Imaging in acute renal infection in children. Daly MJ AJR Am J Roentgenol; 1987 Jul; 149(1):206. PubMed ID: 3035908 [No Abstract] [Full Text] [Related]
19. Poor technetium-99m-dimercaptosuccinic acid renal uptake and tubulointerstitial disease of the kidney. Piers DA; van Luijk WH J Nucl Med; 1993 Feb; 34(2):354. PubMed ID: 8381476 [No Abstract] [Full Text] [Related]
20. 99Tcm(V) DMSA: what is its current role in the management of patients with head and neck cancer? Watkinson J; Clarke S Nucl Med Commun; 1991 Feb; 12(2):79-82. PubMed ID: 1848360 [No Abstract] [Full Text] [Related] [Next] [New Search]